rdf:type |
|
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0021308,
umls-concept:C0178539,
umls-concept:C0205145,
umls-concept:C0206153,
umls-concept:C0262950,
umls-concept:C0271510,
umls-concept:C0332161,
umls-concept:C0806987,
umls-concept:C1511938,
umls-concept:C1522564,
umls-concept:C1999177,
umls-concept:C2004454
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-8-28
|
pubmed:abstractText |
Stem cell therapy in myocardial infarction is under intensive investigation; however, the mechanisms of recovery and the optimal transplantation technique remain controversial. The goal of this controlled and randomized study was to test the hypothesis that locally injected bone marrow-derived mononuclear cells can focus in on the damaged myocardium and improve cardiac function by means of active participation in remodeling.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1097-685X
|
pubmed:author |
pubmed-author:AlaojaHannaH,
pubmed-author:AnttilaVesaV,
pubmed-author:DahlbackaSebastianS,
pubmed-author:JuvonenTatuT,
pubmed-author:KiviluomaKaiK,
pubmed-author:LehenkariPetriP,
pubmed-author:LehtonenSiriS,
pubmed-author:MäkeläJussiJ,
pubmed-author:NiemeläEijaE,
pubmed-author:PaavonenTimoT,
pubmed-author:RimpiläinenJussiJ,
pubmed-author:YlitaloKariK
|
pubmed:issnType |
Electronic
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
565-73
|
pubmed:dateRevised |
2007-10-4
|
pubmed:meshHeading |
|
pubmed:year |
2007
|
pubmed:articleTitle |
Bone marrow-derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site.
|
pubmed:affiliation |
Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|